Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
| Market Cap | 95.10M | P/E | 52.20 | EPS this Y | - | Ern Qtrly Grth | - |
| Income | -482.72k | Forward P/E | - | EPS next Y | - | 50D Avg Chg | 33.00% |
| Sales | - | PEG | - | EPS past 5Y | - | 200D Avg Chg | 33.00% |
| Dividend | N/A | Price/Book | N/A | EPS next 5Y | - | 52W High Chg | -13.00% |
| Recommedations | - | Quick Ratio | 0.03 | Shares Outstanding | 7.29M | 52W Low Chg | 243.00% |
| Insider Own | 19.93% | ROA | - | Shares Float | 4.75M | Beta | - |
| Inst Own | 62.23% | ROE | - | Shares Shorted/Prior | 2.46K/5.29K | Price | 13.05 |
| Gross Margin | - | Profit Margin | - | Avg. Volume | 337,929 | Target Price | - |
| Oper. Margin | - | Earnings Date | - | Volume | 164,801 | Change | 14.57% |
About Ignyte Acquisition Corp.
Ignyte Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. The company intends to focus on target businesses in the life sciences, biotechnology, and healthcare sectors. Ignyte Acquisition Corp. was incorporated in 2020 and is based in New York, New York.